SELLAS Life (SLS) Secures $23.6M to Fuel Late-Stage Cancer Trials
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is a late-stage clinical biopharmaceutical company dedicated to developing innovative therapies for…
Browsing Tag